PreprintCited by 6Telomeres, Telomerase, and SenescenceAlzheimer's disease research and treatmentsGenetics, Aging, and Longevity in Model Organisms

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

DNA damage and senescence in the aging and Alzheimer’s disease cortex are not uniformly distributed

Open access

Preprint — published as 10.3390/biomedicines12061327 · Paper page

Abstract

Alzheimer’s disease (AD) is a neurodegenerative illness with a typical age of onset exceeding 65 years of age. The age-dependency of the condition led us to track the appearance of DNA damage in the frontal cortex of individuals who died with a diagnosis of AD. The focus on DNA damage was motivated by evidence that increasing levels of irreparable DNA damage are a major driver of the aging process. The connection between aging and the loss of genomic integrity is compelling because DNA damage has also been identified as a possible cause of cellular senescence. The number of senescent cells has been reported to increase with age, and their senescence-associated secreted products are likely contributing factors to age-related illnesses. We tracked DNA damage with 53BP1 and cellular senescence with p16 immunostaining of human post-mortem brain samples. We found that DNA damage is significantly increased in the BA9 region of the AD cortex when compared to the same region of unaXected controls (UC). In the AD but not UC cases, the density of cells with DNA damage increased with distance from the pia mater up to approximately layer V then decreased in deeper areas. This pattern of DNA damage was overlaid with the pattern of cellular senescence, which also increased with cortical depth. On a cell-by-cell basis, we found that the intensity of the two markers was tightly linked in the AD, but not the UC brain. To test whether DNA damage was a causal factor in the emergence of the senescence program, we used etoposide treatment to damage the DNA of cultured mouse primary neurons. While DNA damage increased after treatment, after 24 hours no change in the expression of senescence-associated markers was observed. Our work suggests that DNA damage and cellular senescence are both increased in the AD brain and increasingly coupled. We propose that in vivo the relationship between the two age-related processes is more complex than previously thought.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2024.04.28.591529

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 38

  1. 10.3389/fendo.2015.00013 · DOI
  2. 10.1101/cshperspect.a025130 · DOI
  3. 10.1038/s43587-021-00098-4 · DOI · Paper page
  4. 10.1016/j.mad.2008.03.008 · DOI
  5. 10.1016/j.mad.2016.05.006 · DOI · Paper page
  6. 10.1038/nature19329 · DOI · Paper page
  7. 10.1038/nrn4020 · DOI · Paper page
  8. 10.1016/j.tins.2023.11.003 · DOI
  9. 10.1126/science.aao4426 · DOI · Paper page
  10. 10.1038/nature02661 · DOI · Paper page
  11. 10.1038/s41588-022-01279-6 · DOI
  12. 10.1016/j.ajhg.2019.06.005 · DOI · Paper page
  13. 10.1016/j.cell.2005.01.028 · DOI · Paper page
  14. 10.1016/0197-4580(90)90542-8 · DOI · Paper page
  15. 10.1016/S0006-8993(97)81703-9 · DOI
  16. 10.3390/ijms22136748 · DOI · Paper page
  17. 10.1038/s41467-020-16361-y · DOI · Paper page
  18. 10.1186/s40478-019-0723-5 · DOI · Paper page
  19. 10.1016/j.mad.2016.04.005 · DOI · Paper page
  20. 10.1016/j.cell.2023.08.039 · DOI · Paper page
  21. 10.1038/362709a0 · DOI · Paper page
  22. 10.1038/nn.3356 · DOI · Paper page
  23. 10.1016/j.cell.2015.05.032 · DOI · Paper page
  24. 10.1073/pnas.0708043104 · DOI · Paper page
  25. 10.1523/ENEURO.0124-15.2016 · DOI
  26. 10.1038/nrc2440 · DOI · Paper page
  27. 10.1146/annurev-physiol-030212-183653 · DOI · Paper page
  28. 10.1038/s41598-017-17204-5 · DOI · Paper page
  29. 10.1016/j.dnarep.2024.103678 · DOI
  30. 10.1038/s41586-022-04640-1 · DOI · Paper page
  31. 10.3389/fneur.2024.1277613 · DOI
  32. 10.1001/archneurol.2009.15 · DOI · Paper page
  33. 10.1016/S0306-4522(02)00942-9 · DOI · Paper page
  34. 10.1016/S0306-4522(02)00056-8 · DOI
  35. 10.1523/JNEUROSCI.0172-22.2023 · DOI
  36. 10.1097/00001756-199611250-00050 · DOI · Paper page
  37. 10.1007/s007020050104 · DOI · Paper page
  38. 1997, Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer’s disease, Am J Pathol, 150, 1933

Metadata

Authors
Gutta, G., Mehta, J., Kingston, R., Xie, J., Brenner, E., Ma, F., & Herrup, K.
Affiliations
University of Pittsburgh (US)
Corresponding author
Ma, Fulin
Venue
Biomedicines
Publisher
openRxiv
Published
2024-04-30
Volume
12
Issue
6
Pages
1327-1327
ISSN
2227-9059 (ISSN-L)
OpenAlex
W4399670596
Cited by
6
References
2
Citations by year
2026: 2 · 2025: 4
FWCI
1.71
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Biomedicines (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
Funders
  • National Institutes of Health (4100087331)
  • National Institute of Neurological Disorders and Stroke (RF1NS120922, R01NS120922)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
Alzheimer's disease, DNA damage, cellular senescence, brain aging, frontal cortex, 53BP1, p16, cortical depth, postmortem brain, etoposide, senescence-associated secretory phenotype, neuronal senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review